Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Number of holders
-
593
-
Total 13F shares, excl. options
-
73,000,243
-
Shares change
-
+2,468,996
-
Total reported value, excl. options
-
$35,847,977,289
-
Value change
-
+$1,272,746,514
-
Put/Call ratio
-
1.01%
-
Number of buys
-
300
-
Number of sells
-
-243
-
Price
-
$491.14
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q2 2017
695 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2017.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 593 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73,000,243 shares
of 104,986,330 outstanding shares and own 69.53% of the company stock.
Largest 10 shareholders include FMR LLC (7,039,884 shares), Capital World Investors (6,937,863 shares), BlackRock Inc. (6,188,267 shares), WELLINGTON MANAGEMENT GROUP LLP (5,541,185 shares), VANGUARD GROUP INC (5,270,458 shares), STATE STREET CORP (3,290,303 shares), SANDS CAPITAL MANAGEMENT, LLC (2,793,959 shares), Artisan Partners Limited Partnership (1,962,480 shares), LOOMIS SAYLES & CO L P (1,822,296 shares), and POLEN CAPITAL MANAGEMENT LLC (1,586,320 shares).
This table shows the top 593 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.